Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

PSCHvsFMEDETF Comparison

ETF 1
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
+0.15%
VS
ETF 2
FMED

Fidelity Disruptive Medicine ETF

This fund is part of
Multiple Trends
-3.09%

Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. Fidelity Disruptive Medicine ETF (FMED) is part of the Multiple Trends segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.5% for FMED. PSCH is up 20.24% year-to-date (YTD) with -$10M in YTD flows. FMED performs worse with 4.92% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of PSCH and FMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PSCH vs FMED performance and flow charts

Performance

024681012%Jun 24Jul 1Jul 9Jul 16Jul 23

Cumulative Flows

01,000,0002,000,0003,000,0004,000,0005,000,0006,000,000Jun 24Jul 1Jul 9Jul 16Jul 23

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
PSCH
FMED
+5.27%+5.01%
+19.02%+13.03%
+20.24%+4.92%
+36.79%+18.01%
+19.78%+13.15%
-15.14%n/a
Flows
PSCH
FMED
+$6M-
+$9M-$17M
-$10M-$17M
-$13M-$14M
-$133M-$3M
-$230M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
PSCH
FMED
+17.29%+22.48%
+20.07%+19.50%
+21.86%+18.58%
+22.90%n/a
Max drawdown
PSCH
FMED
-2.96%-5.92%
-15.36%-17.78%
-22.80%-21.42%
-46.32%n/a
Max drawdown duration
PSCH
FMED
17d15d
168d212d
488d211d
1786dn/a
Trading data

Create an account to view trading data

Join for free
PSCH
FMED
Last sale
7/24/2026 at 1:30 PM
$52.95
Previous close
07/23/2026
$52.96
Consolidated volume
07/23/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

FMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PSCH
FMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
PSCH
FMED
Last price
$52.95
1D performance
-0.02%
AuM$162.74 M$46.16 M
E/R0.29%0.5%
Characteristics
PSCH
FMED
Management strategyPassiveActive
ProviderInvescoFidelity
BenchmarkS&P SmallCap 600 Capped Health Care Index-
N° of holdings7569
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateApril 7, 2010June 12, 2023
ESGNoNo
Advertisement
Exposure

Countries

PSCH
USA
95.33%
Other
4.67%
FMED
USA
83.89%
Other
16.11%

Sectors

PSCH
Healthcare
100%
Other
0%
FMED
Healthcare
100%
Other
-0%

Diversification

PSCH

Total weight of top 15 holdings out of 15

49.48%
FMED

Total weight of top 15 holdings out of 15

41.87%

Top 15 holdings

Data as of June 30, 2026
PSCH
Molina Healthcare, Inc.
5.29%
BrightSpring Health Services, Inc.
4.82%
Krystal Biotech, Inc.
4.32%
Alkermes Plc
4.06%
Glaukos Corp.
3.75%
Corcept Therapeutics, Inc.
3.69%
Protagonist Therapeutics, Inc.
3.26%
TG Therapeutics, Inc.
3.25%
PTC Therapeutics, Inc.
3.10%
Ligand Pharmaceuticals, Inc.
2.69%
Teleflex, Inc.
2.54%
Liquidia Corp.
2.43%
Indivior Pharmaceuticals, Inc.
2.25%
Veracyte, Inc.
2.13%
RadNet, Inc.
1.90%
FMED
Lifestance Health Group, Inc.
5.11%
10X Genomics, Inc.
3.56%
Danaher Corp.
3.29%
UCB SA
3.09%
Cogent Biosciences, Inc.
2.79%
Bio-Techne Corp.
2.76%
Moderna, Inc.
2.69%
Intuitive Surgical, Inc.
2.49%
argenx SE
2.43%
Alnylam Pharmaceuticals, Inc.
2.41%
Kymera Therapeutics, Inc.
2.36%
UnitedHealth Group, Inc.
2.27%
Thermo Fisher Scientific, Inc.
2.24%
Ascendis Pharma A/S
2.21%
Legend Biotech Corp.
2.17%
Frequently asked questions about PSCH and FMED

How have the PSCH and FMED ETFs performed in 2026?

As of July 24, 2026, PSCH is up 20.24% year-to-date (YTD), while FMED has returned 4.92%. That puts PSCH better performer ahead so far this year.

Which ETF is attracting more investor money: PSCH or FMED?

Year-to-date, the PSCH ETF saw -$10M in flows, compared to -$17M for FMED.

Which ETF is more volatile: PSCH or FMED?

Over the past year, PSCH had a volatility of 20.07%, while FMED experienced 19.5%.

Which ETF is bigger: PSCH or FMED?

As of July 24, 2026, PSCH holds $162.74 M in assets under management (AUM), while FMED manages $46.16 M.

What sectors do the PSCH and FMED ETFs invest in?

PSCH leans toward sectors like Healthcare. Meanwhile, FMED focuses on Healthcare.

What are the top holdings of the PSCH ETF and FMED ETF?

PSCH top holdings include Molina Healthcare, Inc., BrightSpring Health Services, Inc. and Krystal Biotech, Inc.. FMED holds in its top three: Lifestance Health Group, Inc., 10X Genomics, Inc. and Danaher Corp..

Which ETF is more diversified: PSCH or FMED?

PSCH holds 75 securities with 49.48% of its assets in the top 15. FMED has 69 securities and a top 15 weight of 41.87%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026